Characteristic | Results, mean ± SD (range) or n (% of patients) |
---|---|
Demographics | |
Women | 23 (58%) |
Age (years) | 23 ± 7 (22–52) |
Anthropometry | |
Body weight (kg) | 56 ± 9 (37–77) |
BMI | |
< 18.5 | 17 (46%) |
18.5–24.9 | 18 (49%) |
> 25 | 2 (5%) |
HIV infection | |
Time since known HIV seropositivity (months) | 12 ± 7 (5–30) |
CDC clinical stage | |
B | 19 (47%) |
C | 21 (53%) |
CD4+ cell count (cells/mcL) | 133 ± 92 (1–346) |
< 50 | 9 (23%) |
51–200 | 20 (50%) |
> 200 | 11 (27%) |
Viral load (log10 copies/mL) | 5.5 ± 0.4 (4.6–5.9) |
< 5 log | 6 (15%) |
≥ 5 log | 34 (85%) |
Blood cell count and blood chemistry | |
Hemoglobin concentration (g/dL) | 11.5 ± 1.9 (7.7–15.4) |
Neutrophil count (109/L) | 2203 ± 1208 (775–7582) |
Platelets (103/L) | 256 ± 103 (56–493) |
ALT (UI/L) | 23 ± 15 (6–86) |
Amylase (mmol/L) | 90 ± 51 (24–262) |
Triglycerides (mmol/L) | 1.3 ± 0.4 (0.5–2.5) |
Total cholesterol (mmol/L) | 1.6 ± 0.5 (0.9–3.4) |